Indoco Remedies Ltd - 532612 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Indoco Remedies Ltd.'s Baddi Plant-III has received EU GMP certification from the German Health Authority (Berlin). This certification, following an inspection from April 22-27, 2026, confirms the facility's adherence to Good Manufacturing Practice requirements, enhancing its market access.
May 28 2026 16:23:44
Indoco Remedies Limited
Indoco Remedies received EU GMP certification for its Baddi Plant-III from the German Health Authority. This approval confirms the facility's compliance with Good Manufacturing Practice requirements, enhancing its market access in Europe.
May 28 2026 16:18:33
Indoco Remedies Ltd - 532612 - Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements
Indoco Remedies completed the slump sale of its Ophthalmic Division to Sunways (India) Private Limited on May 18, 2026. This strategic transfer encompasses various international territories, including India.
May 18 2026 20:14:58
Indoco Remedies Limited
Indoco Remedies completed the transfer of its Ophthalmic Division to Sunways (India) Private Limited via a slump sale. This divestment covers operations in India and several African territories.
May 18 2026 20:11:10
Indoco Remedies Ltd - 532612 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Indoco Remedies' Baddi Unit-I manufacturing facility has successfully received EU GMP certification from the Malta Medicines Authority. This certification confirms compliance with Good Manufacturing Practice requirements for its solid oral dosage form production.
May 14 2026 11:02:53
Read More